Markel Co. (NYSE:MKL) Vice Chairman Steven A. Markel sold 200 shares of the firm’s stock in a transaction on Thursday, January 18th. The shares were sold at an average price of $1,109.32, for a total value of $221,864.00. Following the transaction, the insider now directly owns 106,560 shares in the company, valued at $118,209,139.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Markel Co. (MKL) opened at $1,121.51 on Tuesday. The stock has a market capitalization of $15,580.00, a PE ratio of 249.78 and a beta of 1.04. Markel Co. has a fifty-two week low of $892.06 and a fifty-two week high of $1,157.30. The company has a current ratio of 0.55, a quick ratio of 0.55 and a debt-to-equity ratio of 0.28.

Markel (NYSE:MKL) last released its earnings results on Wednesday, October 25th. The insurance provider reported ($18.82) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($18.03) by ($0.79). Markel had a return on equity of 0.83% and a net margin of 1.60%. analysts anticipate that Markel Co. will post 5.56 EPS for the current year.

Several large investors have recently added to or reduced their stakes in MKL. Toronto Dominion Bank boosted its position in shares of Markel by 11.0% in the 2nd quarter. Toronto Dominion Bank now owns 171 shares of the insurance provider’s stock valued at $167,000 after purchasing an additional 17 shares during the period. Simplex Trading LLC boosted its position in shares of Markel by 169.1% in the 4th quarter. Simplex Trading LLC now owns 148 shares of the insurance provider’s stock valued at $168,000 after purchasing an additional 93 shares during the period. First Capital Advisors Group LLC. acquired a new position in shares of Markel in the 3rd quarter valued at $202,000. Quantbot Technologies LP boosted its position in shares of Markel by 775.0% in the 2nd quarter. Quantbot Technologies LP now owns 210 shares of the insurance provider’s stock valued at $204,000 after purchasing an additional 186 shares during the period. Finally, Archford Capital Strategies LLC boosted its position in shares of Markel by 34,592.5% in the 2nd quarter. Archford Capital Strategies LLC now owns 13,877 shares of the insurance provider’s stock valued at $204,000 after purchasing an additional 13,837 shares during the period. Institutional investors and hedge funds own 76.76% of the company’s stock.

A number of research firms recently issued reports on MKL. Zacks Investment Research lowered Markel from a “buy” rating to a “hold” rating in a report on Thursday, January 11th. Royal Bank of Canada reaffirmed a “hold” rating and set a $1,050.00 target price on shares of Markel in a report on Tuesday, October 3rd. SunTrust Banks reaffirmed a “hold” rating and set a $1,100.00 target price on shares of Markel in a report on Friday, October 27th. Finally, Boenning Scattergood reaffirmed a “buy” rating on shares of Markel in a report on Thursday, October 26th. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $1,109.50.

COPYRIGHT VIOLATION NOTICE: This piece was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another website, it was stolen and reposted in violation of international copyright & trademark legislation. The correct version of this piece can be read at https://www.thecerbatgem.com/2018/01/23/markel-co-mkl-vice-chairman-sells-221864-00-in-stock.html.

Markel Company Profile

Markel Corporation is a financial holding company serving a range of markets. The Company’s principal business markets and underwrites specialty insurance products. It monitors and reports its ongoing underwriting operations in three segments: U.S. Insurance, International Insurance and Reinsurance. The Company, through its subsidiary Markel Ventures, Inc (Markel Ventures), owns interests in various industrial and service businesses that operate outside of the specialty insurance marketplace.

Insider Buying and Selling by Quarter for Markel (NYSE:MKL)

Receive News & Ratings for Markel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel and related companies with MarketBeat.com's FREE daily email newsletter.